iBB
58.2K views | +0 today
Follow
iBB
Institute for Bioengineering and Biosciences
Curated by iBB
Your new post is loading...
Your new post is loading...
Scoop.it!

Towards Cost-effective Stem Cell-based Therapies for Type 1 Diabetes

Towards Cost-effective Stem Cell-based Therapies for Type 1 Diabetes | iBB | Scoop.it

Type 1 diabetes is an auto-immune disease where patients need to monitor and take insulin daily. Transplantation of encapsulated islet cells is performed in some countries to restore glucose control, but shortage of donors is a major bottleneck. Devices with stem cell-derived beta cells are now in clinical trials. Researchers at SCERG-iBB and Harvard Medical School performed an early health technology assessment modeling study to simulate, based on bioprocess and disease progression modeling, the manufacturing costs of devices containing pluripotent stem cell (PSC)-derived beta cells. This information was combined with medical data to determine cost-effectiveness of the new therapy. The work was published in Biotechnology Journal.

No comment yet.
Scoop.it!

Tânia Baltazar Defends PhD Thesis in Bioengineering

Tânia Baltazar Defends PhD Thesis in Bioengineering | iBB | Scoop.it

Tânia Daniela Cavaleiras Baltazar will be defending her PhD thesis in Bioengineering (Cell Therapies and Regenerative Medicine) at Instituto Superior Técnico, thursday the 21st March 2019 (12:30 H, room PA3). During the last years, and under the supervision of Frederico Ferreira from SCERG-iBB and Pankaj Karande from RPI, Tânia focused her efforts on the development of a 3D printed in vitro vascularized human skin model for clinical applications. The title of her thesis is "Design and Fabrication of Full-Thickness Vascularized Human Skin With 3D Bioprinting Technology”.

No comment yet.
Scoop.it!

Xylanase Production with Unconventional Yeast and Brewery Spent Grains

Xylanase Production with Unconventional Yeast and Brewery Spent Grains | iBB | Scoop.it

Xylanases play a crucial role in the hydrolysis of xylan-rich hemicelluloses and have wide industrial applications in the fuel, food, feed and pulp and paper industries. Obtaining these enzymes at low cost is of paramount importance for their commercial deployment. Their production has been reported mainly from fungi, while low activity levels are typically obtained from yeast. BERG-iBB researchers in collaboration with colleagues from the National Laboratory of Energy and Geology are exploring the potential of the unconventional yeast, Moesziomyces aphidis as a xylanases producer. Brewery spent grain was found as a potent inducer for high xylanase production activity, where extracellular crude extracts presented cellulase-free xylanolytic activity. The work was published in New Biotechnology Journal.    

No comment yet.
Scoop.it!

Cell-derived Electrospun Microfibrous Scaffolds for Bone Tissue Engineering

Cell-derived Electrospun Microfibrous Scaffolds for Bone Tissue Engineering | iBB | Scoop.it

Cell-derived extracellular matrix (ECM) has been employed as scaffolds for tissue engineering. SCERG-iBB researchers working with colleagues from the Rensselaer Polytechnic developed bioactive cell-derived ECM electrospun polycaprolactone (PCL) scaffolds produced from ECM derived from human mesenchymal stem/stromal cells (MSC), human umbilical vein endothelial cells (HUVEC) and their combination based on the hypothesis that the cell-derived ECM incorporated into the PCL fibers would enhance the biofunctionality of the scaffold. The findings show that all cell-derived ECM electrospun scaffolds promoted significant cell proliferation compared to PCL alone, while presenting similar physical/mechanical properties. Additionally, MSC:HUVEC-ECM electrospun scaffolds significantly enhanced osteogenic differentiation of MSCs. The study was published in Materials Science and Engineering: C.

No comment yet.
Scoop.it!

Alginate Encapsulation of Human Mesenchymal Stem/Stromal Cells

Alginate Encapsulation of Human Mesenchymal Stem/Stromal Cells | iBB | Scoop.it
Mesenchymal stem/stromal cells (MSC) can stimulate tissue regeneration during wound healing. SCERG-iBB researchers Cláudia Lobato Silva, Frederico Ferreira and Joaquim Cabral, working in collaboration with Todd McDevittt from UCSF, propose the use of alginate encapsulation as a strategy to assess the activity of 3D- and 2D-cultured human bone marrow MSC in the setting of wound repair and regeneration processes. The study, published in Journal of Biotechnology, shows that encapsulation within alginate matrices protects MSC from oxidative stress and extends its therapeutic potential. Click on title to learn more.
No comment yet.
Scoop.it!

Marisa Santos Defends PhD Thesis in Bioengineering

Marisa Santos Defends PhD Thesis in Bioengineering | iBB | Scoop.it
Marisa Andreia Viegas dos Santos will be defending her Ph D thesis in Bioengineering (MIT Portugal program) at Instituto Superior Técnico, thursday the 24th july 2017 (10:30 H, room PA.3). During the last years, and under the supervision of Frederico Ferreira from BERG-iBB, Marisa focused her efforts on the use of the yeast Moesziomyces antarcticus as a cell factory for the biosynthesis of surface active glycolipids of the mannosylerythritol class. The title of Marisa's thesis is “Mannosylerythritol lipids bioproduction by Moesziomyces antarcticus: Sequential stages approach”.
No comment yet.
Scoop.it!

Marta Costa Defends PhD Thesis in Bioengineering

Marta Costa Defends PhD Thesis in Bioengineering | iBB | Scoop.it
Marta Costa will be defending her Ph D thesis in Bioengineering (MIT Portugal program) at Instituto Superior Técnico, friday the 24th may 2017 (11:00 H, room PA3). During the last years, and under the supervision of Frederico Ferreira and Cláudia Lobato Silva from SCERG-IBB, and from Todd McDevitt from the USA, Cláudia focused her efforts on the manipulation of the microenvironment of MSCs. The title of Marta's thesis is “Engineering the microenvironment of Mesenchymal Stem/Stromal Cells (MSC) to tune their trophic activity”.
No comment yet.
Scoop.it!

Gelatin Scaffolds for Skin Tissue Engineering

Gelatin Scaffolds for Skin Tissue Engineering | iBB | Scoop.it

Gelatin’s excellent foaming ability allows the application of in situ gas foaming as a preparation technique for porous scaffold development. Ina  recent publication in the International Journal of Polymeric Materials and Polymeric Biomaterials, a team of researchers from BERG-iBB, and from The University of Northampton, report on a new iterative experimental design for the preparation of gellatin scafolds by an in situ gas foaming method . The prepared scaffolds were studied for applying the findings to the future skin tissue engineering scaffolds. The thermal stability, mechanical properties, and pore structure of the scaffolds are reported and their degradation resistance by using collagenase enzyme and their cytotoxicity by using fibroblasts were studied. The results of this study demonstrated that gas foaming method can be modified to produce an interconnected porous structure with enhanced mechanical properties. Click on title to learn more.

No comment yet.
Scoop.it!

5th Advanced Course on Regenerative Medicine

5th Advanced Course on Regenerative Medicine | iBB | Scoop.it

"The 5th Advanced Course on Regenerative Medicine will take place on 11th of December 2015. It is organized by the Centre for Rapid and Sustainable Product Development (CDRSP) and it aims to illustrate the state-of-the-art regarding the principles and methodologies associated with Regenerative Medicine. The course joins a unique group of worldwide renowned experts with the aim of contributing for the exchange of the scientific knowledge on cells, biomaterials and strategies for tissue regeneration. Furthermore, it is intended that attendees have the opportunity to discuss ideas directly with the invited speakers."

 

iBB's insight:

Frederico Ferreira from BERG-iBB will deliver an oral presentation entitled "Ex-vivo cultivation of stem cells: biomaterial’s contribution".

No comment yet.
Scoop.it!

Production of Platelets and Their Progenitors From Umbilical Cord Blood

Production of  Platelets and Their Progenitors From Umbilical Cord Blood | iBB | Scoop.it

Platelet transfusion can be a life-saving procedure in different medical settings, but shelf-life of this plod product is only 5 days. The efficient ex vivobiomanufacturing of platelets would make it possible toovercome the shortages of donated platelets. The optimized protocol described by BERG researchers in a recent paper published in the journal Cythotherapy allows the efficient production of platelets and their progenitors from blood stem/progenitor cells by mimicking the bone marrow niche through a co-culture system with human mesenchymal stromal cells (MSC), in combination with different biological factors to prompt differentiation toward functional platelets. Click on title to learn more.

 

Photo details: SEM image from blood shwoing small disc-shaped platelets among other red and white blood cells. Bruce Wetzel, NCI, 1982, public domain. 

No comment yet.
Scoop.it!

Moesziomyces antarcticus Production of MEL from Lignocellulose Hydrolysates (JCTB cover)

Moesziomyces antarcticus Production of MEL from Lignocellulose Hydrolysates (JCTB cover) | iBB | Scoop.it

Moesziomyces antarcticus is an efficient producer of mannosylerythritol lipids (MEL), a biosurfactant with a wide range of potential applications. The use of lignocellulosic biomass can contribute to sustainable MEL production. While lignocellulosic sugars (e.g. D-glucose and D-xylose) can be converted to MEL, the required pretreatment of lignocellulosic biomass releases by products that are potentially inhibitory for yeasts. A recent publication by Marisa Santos, Nuno Faria and Frederico Ferreira from BERG-iBB , in collaboration with César Fonseca from LNEG, describes a design of experiment (DoE) that was performed to evaluate the effect of furfural, acetate and formate on M. antarcticus and its capacity to produce MEL from lignocellulose hydrolysates. The study provides insight into the conditions required by M. antarcticus for MEL production from lignocellulosic hydrolysates and points towards further process and strain development requirements. The work was published in Journal of Chemical Technology and Biotechnology and made it to the cover of the journal.

 

Image details: JCTB cover,  copyright by Marisa V. Santos, 2018. Acknowledgements: FCT grant CRUISE (PTDC/AAG‐TEC/0696/2014)

No comment yet.
Scoop.it!

Screening Resins for Simultaneous Removal of Genotoxins from APIs

Screening Resins for Simultaneous Removal of Genotoxins from APIs | iBB | Scoop.it

A detailed investigation on the assessment of commercial resins for genotoxins removal in organic solvent solutions has just been published by Teresa Esteves, Flávio Ferreira and Frederico Ferreira from BERG-iBB, in collaboration with Hovione. The study addresses mitigation of active pharmaceutical ingredient (API) loss during purification in recrystallization mother liquors by including a resin adsorption step to remove potential genotoxin impurities (PGTIs). Two resins were identified, AG 50W-X2 and IRA68, to efficiently remove an aromatic amine (4-dimethylaminopyridine) and a sulfonate ester (methyl p-toluenesulfonate) from methanol solutions, respectively, with adsorptions higher than 98% and an API loss lower than 10% using these resins combined in a single adsorption step. The potential for improving the API recrystallization economics, through mitigation of API losses is also suggested. Mometasone furoate (Meta) was used as model active pharmaceutical ingredient (API) in the presence of 4-dimethylaminopyridine (DMAP) and methyl p-toluenesulfonate (MPTS) as two model PGTIs. The work was published in the journal Separation Science and Technology.

No comment yet.
Scoop.it!

Compositional and Structural Analysis of GAGs in Cell-Derived ECM

Compositional and Structural Analysis of GAGs in Cell-Derived ECM | iBB | Scoop.it

Cell-derived ECM have emerged as promising materials for regenerative medicine due to their ability to recapitulate the native tissue microenvironment. However, little is known about the glycosaminoglycan (GAG) composition of these cell-derived ECM. In a recent study published in Glycoconjugate Journal, researchers from SCERG-iBB, working in collaboration with colleagues from the Rensselaer Polytechnic Institute, characterized three different cell-derived ECM in terms of their GAG content, composition and sulfation patterns using a highly sensitive LC-MS/MS technique. Distinct GAG compositions and disaccharide sulfation patterns were verified for the different cell-derived ECM. Additionally, the effect of decellularization method on the GAG and disaccharide relative composition was also assessed. The method offers a novel approach to determine the GAG composition of cell-derived ECM, which we believe is critical for a better understanding of ECM role in directing cellular responses and has the potential for generating important knowledge for the development of new ECM-like biomaterials for tissue engineering applications.

No comment yet.
Scoop.it!

Miriam Sousa Defends PhD Thesis in Biotechnology and Biosciences

Miriam Sousa Defends PhD Thesis in Biotechnology and Biosciences | iBB | Scoop.it

Miriam Sousa will be defending her PhD thesis in Biotechnology and Biosciences at Instituto Superior Técnico, wednesday the 19th October 2018 (14:00 H, room PA3). During the last years, and under the supervision of Frederico Ferreira from SCERG-iBB, Miriam developed nanofiber scaffolds for the cultivation of neural stem cells. The title of her thesis is "Ex-Vivo Culture of Neural Stem Cells in Nanofiber Scaffolds: Cellular Organization and Dynamic Systems”.

No comment yet.
Scoop.it!

Computational Models for Designing Stem Cell Manufacturing Processes

Computational Models for Designing Stem Cell Manufacturing Processes | iBB | Scoop.it

Current stem cell process design is guided by the envisioned demand and compliance with regulatory requirements. However, design of manufacturing processes streamlining for cost efficiency, while preparing a new therapy for approval and reimbursement, is often neglected. In an editorial of RegMedNet, a networking site that unites all members of the diverse regenerative medicine community, the use of computational models for designing stem cell manufacturing processes is discussed by SCERG-iBB researchers led by Joaquim Cabral in collaboration with Stan Finkelstein from MIT. Click on title to learn more.

No comment yet.
Scoop.it!

API Degenotoxification with Adenine-Functionalized Polymers

API Degenotoxification with Adenine-Functionalized Polymers | iBB | Scoop.it
Sulfonate genotoxic impurity (GTIs) pose a high risk for human health due to their ability to alkylate DNA. Removal of such GTIs from pharmaceutical formulations (<1.5 µg/day) is thus a regulatory requirement. In a recent study performed by Teresa Esteves and Frederico Ferreira from BERG-iBB, in collaboration with researchers from Faculty of Pharmacy (UL), propose using a polybenzimidazole (PBI) polymer modified with a DNA base to remove sulfonated GTIs. The polymer was able to efficiently remove the GTI from solutions prepared in dichloromethane, removing more than 96% of the impurity as compared to only about 10% for the original non-modified polymer. Click on title to learn more. 
No comment yet.
Scoop.it!

Imprinted Polymers Tailored for Degenotoxification of Pharmaceuticals

Imprinted Polymers Tailored for Degenotoxification of Pharmaceuticals | iBB | Scoop.it
The presence of genotoxic impurities (GTIs) (e.g. reagents, intermediates, side-products) in active pharmaceutical ingredients (APIs) constitutes a high risk for human health. For this reason, regulatory authorities have established that the intake of these DNA reactive impurities should not exceed the threshold limit of 1.5 µg/day. In a recent study published in the journal Separation and Purification Technology, Teresa Esteves and Frederico Ferreira from BERG-iBB, in collaboration with researchers from Hovione and FCT-UNova, present a novel molecular imprinted polymer (MIP) that is able to efficiently remove the GTI 4-dimethylaminopyridine at concentrations as high as 1 g/L. Two case studies relevant for the pharmaceutical industry are evaluated, and a multistep configuration is proposed comprising a MIP-based step and organic solvent nanofiltration, that reduces GTI content below the limits imposed by law. Click on title to learn more.
No comment yet.
Scoop.it!

“Green Detergents” Wins the Green Project Awards Portugal

“Green Detergents” Wins the Green Project Awards Portugal | iBB | Scoop.it

The project "Green Detergents: biosurfactants from lignocellulosic biomass" has just won the 8th edition of the Green Project Awards Portugal (2015) in the category Research and Development. The core team is composed by Nuno Faria (PhD, MIT Portugal Program graduate), Frederico Ferreira (iBB-IST) and César Fonseca (PhD, former Researcher at LNEG, Professor at Aalborg University. The prize was awarded by Quercus, the Portuguese Environment Agency (APA), and GCI, to foster sustainable development. The new technology aims at producing biodegradable and non-toxic biosurfactants (detergents) from renewable resources (agricultural and forest wastes) as alternative to oil-based products. Unlike most of current detergents, the target biosurfactants are compatible with applications in household cleaners/detergents, cosmetics, drug delivery, among others. The team intends to continue developing the technology towards commercialization. In addition to the international patent, the team has several publications on the subject in international scientific journals and contributed for the training of 2 PhD and 3 MSc students.

No comment yet.
Scoop.it!

R&D Project from LNEG, iBB-IST and MIT Portugal at the Final Stage of the Green Project Awards Portugal

R&D Project from LNEG, iBB-IST and MIT Portugal at the Final Stage of the Green Project Awards Portugal | iBB | Scoop.it

The project "Green Detergents: biosurfactants from lignocellulosic biomass" was submitted to the 8th edition of the Green Project Awards Portugal (2015) in the category Research and Development. The core team was composed by Nuno Faria (MIT Portugal Program graduate), Frederico Ferreira (iBB-IST) and César Fonseca (Invited Researcher at LNEG). This project generated a technology for the production of biosurfactants from lignocellulosic residues (e.g. wheat straw) via biological conversion. These biosurfactants are glycolipids, mannosylerythritol lipids (MEL), produced by yeasts (Pseudozyma spp.). Generally, the use of biosurfactants has significant advantages over synthetic surfactants, like higher biodegradability, less toxicity, milder production conditions and higher molecular complexity, which promotes unique biochemical properties. The properties of these biosurfactants (MEL) are compatible with their use in the following applications: household cleaners/detergents, cosmetics, drug delivery, among others. The technology proposed for MEL production offers advantages over the existent technology used by Asian companies, including the reduction of raw materials costs, independence of the food value-chain and straightforward product purification

No comment yet.
Scoop.it!

Javad Hatami Defends PhD Thesis in Bioengineering

Javad Hatami Defends PhD Thesis in Bioengineering | iBB | Scoop.it

Javad Hatami defends his Ph D thesis in Bioengineering at Instituto Superior Técnico, monday the 27th April 2015. During the last years, and under the supervision of Frederico Ferreira and Cláudia Lobato Silva from BERG-iBB, Javad has investigated strategies to produce platelets from stem cells.  The title of his thesis is “Engineering The Microenvironment Of Human Umbilical Cord Blood Hematopoietic Stem/Progenitor Cells Towards Efficient Megakaryocytic Lineage Differentiation And Platelet Production Ex‐vivo”. 

No comment yet.